1-20 of 49
Vernon E. Steele
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat

Venkateshwar Madka, Gaurav Kumar, Gopal Pathuri, Janani Panneerselvam, Yuting Zhang, Vishal Ganta, Stanley Lightfoot, Ronald Lubet, Chen S. Suen, Vernon E. Steele, Naveena B. Janakiram, Altaf Mohammed, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2021) 14 (11): 1009–1020.
https://doi.org/10.1158/1940-6207.CAPR-21-0057
Published: 01 November 2021
View articletitled, Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat
Open the PDF for Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat in another window
Includes: Supplementary data
Journal Articles

Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model

Venkateshwar Madka, Gaurav Kumar, Gopal Pathuri, Yuting Zhang, Stanley Lightfoot, Adam S. Asch, Altaf Mohammed, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2020) 13 (2): 185–194.
https://doi.org/10.1158/1940-6207.CAPR-19-0265
Published: 05 February 2020
View articletitled, Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model
Open the PDF for Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model in another window
Includes: Supplementary data
Journal Articles

Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Yuting Zhang, Anil Singh, Laura Biddick, Qian Li, Stanley Lightfoot, Vernon E. Steele, Ronald A. Lubet, Chen S. Suen, Mark Steven Miller, Shizuko Sei, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (11): 751–762.
https://doi.org/10.1158/1940-6207.CAPR-19-0312
Published: 01 November 2019
View articletitled, Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma
Open the PDF for Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma in another window
Includes: Supplementary data
Journal Articles

Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide

Arthur R. Galbraith, Donna E. Seabloom, Beverly R. Wuertz, Jennifer D. Antonides, Vernon E. Steele, Lee W. Wattenberg, Frank G. Ondrey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (2): 69–78.
https://doi.org/10.1158/1940-6207.CAPR-17-0402
Published: 05 February 2019
View articletitled, Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide
Open the PDF for Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide in another window
Includes: Supplementary data
Journal Articles

Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression

Ronald A. Lubet, Vernon E. Steele, Robert H. Shoemaker, Clinton J. Grubbs
Journal: Cancer Prevention Research
Series: Author Choice
Cancer Prev Res (Phila) (2018) 11 (10): 595–606.
https://doi.org/10.1158/1940-6207.CAPR-18-0084
Published: 02 October 2018
View articletitled, Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression
Open the PDF for Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression in another window
Includes: Supplementary data
Journal Articles

Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice

Donna E. Seabloom, Arthur R. Galbraith, Anna M. Haynes, Jennifer D. Antonides, Beverly R. Wuertz, Wendy A. Miller, Kimberly A. Miller, Vernon E. Steele, Chen S. Suen, M. Gerard O'Sullivan, Frank G. Ondrey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (2): 124–132.
https://doi.org/10.1158/1940-6207.CAPR-16-0174
Published: 02 February 2017
View articletitled, Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice
Open the PDF for Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice in another window
Journal Articles

Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention

Donna E. Seabloom, Arthur R. Galbraith, Anna M. Haynes, Jennifer D. Antonides, Beverly R. Wuertz, Wendy A. Miller, Kimberly A. Miller, Vernon E. Steele, Mark Steven Miller, Margie L. Clapper, M. Gerard O'Sullivan, Frank G. Ondrey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2017) 10 (2): 116–123.
https://doi.org/10.1158/1940-6207.CAPR-16-0232
Published: 02 February 2017
View articletitled, Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention
Open the PDF for Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention in another window
Includes: Supplementary data
Journal Articles

5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?

Ronald A. Lubet, Reid Townsend, Margie L. Clapper, M. Margaret Juliana, Vernon E. Steele, David L. McCormick, Clinton J. Grubbs
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (7): 616–623.
https://doi.org/10.1158/1940-6207.CAPR-15-0294
Published: 30 June 2016
View articletitled, 5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
Open the PDF for 5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target? in another window
Includes: Supplementary data
Journal Articles

Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo

Venkateshwar Madka, Altaf Mohammed, Qian Li, Yuting Zhang, Laura Biddick, Jagan M.R. Patlolla, Stan Lightfoot, Rheal A. Towner, Xue-Ru Wu, Vernon E. Steele, Levy Kopelovich, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2016) 9 (1): 53–62.
https://doi.org/10.1158/1940-6207.CAPR-15-0199
Published: 06 January 2016
View articletitled, Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo
Open the PDF for Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo in another window
Includes: Supplementary data
Journal Articles

Abstract PR09: Intermittent dosing regimens maintain efficacy of several cancer preventing drugs

Vernon E. Steele, Clinton J. Grubbs, Ronald A. Lubet
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (10_Supplement): PR09.
https://doi.org/10.1158/1940-6215.PREV-14-PR09
Published: 02 October 2015
View articletitled, Abstract PR09: Intermittent dosing regimens maintain efficacy of several cancer preventing drugs
Journal Articles

Abstract B53: Predicting efficacy of chemopreventive agents in animal tumor assays by statistical modeling

Barbara K. Dunn, Vernon E. Steele, Richard M. Fagerstrom, Carol F. Topp, David Ransohoff, Leslie G. Ford, Barnett S. Kramer
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (10_Supplement): B53.
https://doi.org/10.1158/1940-6215.PREV-14-B53
Published: 02 October 2015
View articletitled, Abstract B53: Predicting efficacy of chemopreventive agents in animal tumor assays by statistical modeling
Journal Articles

Abstract B54: Current intervention strategies in the NCI PREVENT Cancer Preclinical Drug Development Program

Robert H. Shoemaker, Barbara K. Dunn, Chen Suen, Dan L. Boring, Brian D. Klein, Mark S. Miller, Vernon E. Steele
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (10_Supplement): B54.
https://doi.org/10.1158/1940-6215.PREV-14-B54
Published: 02 October 2015
View articletitled, Abstract B54: Current intervention strategies in the NCI PREVENT Cancer Preclinical Drug Development Program
Journal Articles

Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy

Ronald A. Lubet, James M. Scheiman, Ann Bode, Jonathan White, Lori Minasian, M. Margaret Juliana, Daniel L. Boring, Vernon E. Steele, Clinton J. Grubbs
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (4): 296–302.
https://doi.org/10.1158/1940-6207.CAPR-14-0347
Published: 31 March 2015
View articletitled, Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
Open the PDF for Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy in another window
Includes: Supplementary data
Journal Articles

Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis

Naveena B. Janakiram, Altaf Mohammed, Taylor Bryant, Stan Lightfoot, Peter D. Collin, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (4): 327–337.
https://doi.org/10.1158/1940-6207.CAPR-14-0380
Published: 31 March 2015
View articletitled, Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis
Open the PDF for Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models

Matthew D. Thompson, Clinton J. Grubbs, Ann M. Bode, Joel M. Reid, Renee McGovern, Philip S. Bernard, Inge J. Stijleman, Jeffrey E. Green, Christina Bennett, M. Margaret Juliana, Fariba Moeinpour, Vernon E. Steele, Ronald A. Lubet
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (3): 231–239.
https://doi.org/10.1158/1940-6207.CAPR-14-0181-T
Published: 05 March 2015
View articletitled, Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models
Open the PDF for Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models in another window
Journal Articles

Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Rebekah L. Ritchie, Misty Brewer, Laura Biddick, Jagan Mohan R. Patlolla, Michael Sadeghi, Stan Lightfoot, Vernon E. Steele, Chinthalapally V. Rao
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2014) 7 (12): 1198–1209.
https://doi.org/10.1158/1940-6207.CAPR-14-0176
Published: 01 December 2014
View articletitled, Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling
Open the PDF for Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling in another window
Includes: Supplementary data
Journal Articles

Abstract A41: Evaluation of maximum tolerated dose of aerosolized Rapamycin in A/J mice

Sheela Sharma, Jin Lee, Jianliang Zhou, Brian Wong, Vernon E. Steele
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A41.
https://doi.org/10.1158/1940-6207.PREV-10-A41
Published: 24 October 2014
View articletitled, Abstract A41: Evaluation of maximum tolerated dose of aerosolized Rapamycin in A/J mice
Journal Articles

Abstract A101: Dose-related suppression of rat oral carcinogenesis by the EGF receptor-tyrosine kinase inhibitor, gefitinib

Thomas L. Horn, William D. Johnson, Ronald A. Lubet, Vernon E. Steele, David L. McCormick
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): A101.
https://doi.org/10.1158/1940-6207.PREV-10-A101
Published: 24 October 2014
View articletitled, Abstract A101: Dose-related suppression of rat oral carcinogenesis by the EGF receptor-tyrosine kinase inhibitor, gefitinib
Journal Articles

Abstract B48: Lack of efficacy of the anti-diabetic drug metformin in the ER+ methylnitrosourea (MNU)-induced and the ER- MMTV-Neu/p53KO models of mammary cancer

Ronald A. Lubet, Ann M. Bode, Vernon E. Steele, Clinton J. Grubbs
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): B48.
https://doi.org/10.1158/1940-6207.PREV-10-B48
Published: 24 October 2014
View articletitled, Abstract B48: Lack of efficacy of the anti-diabetic drug metformin in the ER+ methylnitrosourea (MNU)-induced and the ER- MMTV-Neu/p53KO models of mammary cancer
Journal Articles

Abstract B49: Use of MMTV-Neu/P53 KO transgenic mice to screen for potential chemopreventive agents

Ronald A. Lubet, Clinton J. Grubbs, Margaret Juliana, Ann Bode, Vernon E. Steele, Kenneth Iwata
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): B49.
https://doi.org/10.1158/1940-6207.PREV-10-B49
Published: 24 October 2014
View articletitled, Abstract B49: Use of MMTV-Neu/P53 KO transgenic mice to screen for potential chemopreventive agents